BioCrete ApS: Financial statements 2022
CVR: 41353430
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BioCrete ApS (CVR 41353430) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 589,571 and a net result of DKK -758,126 compared with DKK 1,017,312 the year before. That is a decrease of 47.9% compared with the year before. Equity in the 2022 report amounted to DKK 428,036. The solvency ratio was 98.2%.
- Gross Profit
- DKK 589,571
- Profit/Loss
- DKK -758,126
- Equity
- DKK 428,036
- Total Assets
- DKK 436,036
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 590 t. | -758 t. | 428 t. | - |
| 2021 | - | 1.1 mio. | 1 mio. | 1.2 mio. | - |
Official annual report
Keep an eye on BioCrete ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BioCrete ApS has published its annual report for 2021. Gross profit came to DKK 1,132,567, and the net result was DKK 1,017,312.
About BioCrete ApS
BioCrete ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lasse Nørbye Døssing. The company's owners include CemGreen ApS, COPAseed A/S and Sean Crowe Holdings Ltd.. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -23,990 and a net result of DKK -33,465 compared with DKK -26,885 the year before. Equity in the 2025 report amounted to DKK 81,495.